Table 2.
Name | UTR on mRNA | Expression, tissue | Reference |
---|---|---|---|
miR-93 miR-98 | 3’ | Expressed at higher levels in SCLC lines compared to NSCLC lines and immortalized human bronchial epithelial cells (HBECs); miR-93 binds to TUSC2P mRNA (see below) | [55, 61] |
miR-663 | 3’ | Ovarian cancer | [56] |
miR-197 | 3’ | Expressed at higher levels in both SCLC and NSCLC compared to HBECs | [55] |
miR-19a | 3’ | Lung cancer | [57] |
miR-378 | 3’ | Mesenchymal stem cells | [58] |
miR-584 | 3’ | Thyroid cancer | [59] |
miR-138 | 5’ | Triple-negative breast cancer | [60] |
miR-17 miR-93 miR-299-3p miR-520a miR-608 miR-661 |
3’ | Binds to TUSC2P mRNA expressed at high levels in normal cells (human white blood cells, human keratinocyte cell line HaCaT, and human bronchial epithelial cell line BEAS-2B). TUSC2P mRNA expressed at low levels in human breast cancer cell lines (MDA-MB231, MB468 and MT-1), a human glioblastoma cell line U87, and a mouse breast cancer cell line 4T1 | [61] |